fulvestrant has been researched along with 2-methoxyestradiol in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubey, RK; Fingerle, J; Gillespie, DG; Jackson, EK; Korzekwa, KR; Rosselli, M; Zacharia, LC | 1 |
| Dubey, RK; Imthurn, B; Jackson, EK; Keller, PJ; Rosselli, M | 1 |
| Baylis, C; Dubey, RK; Gillespie, DG; Jackson, EK; Xiao, S | 1 |
| Kennedy, AM; Maran, A; Rickard, DJ; Sibonga, JD; Spelsberg, TC; Turner, RT; Zhang, M | 1 |
| Green, SJ; Herbstritt, CJ; Kough, EC; LaVallee, TM; Pribluda, VS; Zhan, XH | 1 |
| Huang, CW; Liu, YC; Lo, YC; Wu, SN | 1 |
| Gorny, G; Maran, A; Oursler, MJ; Shogren, KL; Turner, RT; Yaszemski, MJ; Zhang, M | 1 |
| Dubey, RK; Imesch, P; Leeners, B; Samartzis, EP; Twiehaus, A | 1 |
| Buñay, J; Castro, A; Florez, M; Molina, C; Moreno, RD; Orihuela, PA; Parada-Bustamante, A; Valencia, C | 1 |
| Gorska, M; Kuban-Jankowska, A; Wozniak, M; Wyszkowska, RM | 1 |
10 other study(ies) available for fulvestrant and 2-methoxyestradiol
| Article | Year |
|---|---|
Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms.
Topics: 2-Methoxyestradiol; Animals; Aorta; Aorta, Thoracic; Catechol O-Methyltransferase; Cell Count; Cell Division; Cell Line; Cells, Cultured; Cytochrome P-450 Enzyme System; Cytosol; DNA; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Flavonoids; Fulvestrant; Humans; Inhibitory Concentration 50; Luteolin; Male; MAP Kinase Signaling System; Models, Biological; Muscle, Smooth, Vascular; Protein Binding; Quercetin; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Sex Factors; Time Factors; Tumor Cells, Cultured | 2000 |
Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism.
Topics: 2-Methoxyestradiol; Animals; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Endothelins; Estradiol; Estrogen Receptor beta; Female; Fulvestrant; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Receptors, Estrogen; Swine; Time Factors | 2001 |
Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth.
Topics: 2-Methoxyestradiol; Cell Division; Cells, Cultured; Endothelium, Vascular; Estradiol; Fulvestrant; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Humans; Kidney Glomerulus; Nitric Oxide; Nitric Oxide Synthase; Progestins; Receptors, Estrogen | 2001 |
2-methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells.
Topics: 2-Methoxyestradiol; Animals; Apoptosis; Bone Matrix; Bone Neoplasms; Cell Survival; Cytokines; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Gene Expression Regulation, Neoplastic; Growth Substances; Humans; Interferons; Osteoblasts; Osteosarcoma; Rats; Tumor Cells, Cultured | 2002 |
2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
Topics: 2-Methoxyestradiol; Apoptosis; Breast Neoplasms; Cell Division; Cytochrome P-450 Enzyme Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Flavonoids; Fulvestrant; Humans; Receptors, Estrogen; Tumor Cells, Cultured | 2002 |
Inhibitory action of ICI-182,780, an estrogen receptor antagonist, on BK(Ca) channel activity in cultured endothelial cells of human coronary artery.
Topics: 2-Methoxyestradiol; Biphenyl Compounds; Cell Division; Cells, Cultured; Coronary Vessels; Drug Interactions; Endothelium, Vascular; Estradiol; Fulvestrant; Humans; Kinetics; Lignans; Masoprocol; Membrane Potentials; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Receptors, Estrogen | 2003 |
2-methoxyestradiol inhibits differentiation and is cytotoxic to osteoclasts.
Topics: 2-Methoxyestradiol; Animals; Apoptosis; Bone Resorption; Cell Differentiation; Cell Line; Cell Survival; Cells, Cultured; Cytokines; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Lymphotoxin-alpha; Lymphotoxin-beta; Membrane Proteins; Mice; Osteoclasts; Rats; RNA, Messenger | 2006 |
The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen-receptor-independent manner.
Topics: 2-Methoxyestradiol; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Endometriosis; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans | 2016 |
2-hydroxyoestradiol and 2-methoxyoestradiol, two endogenous oestradiol metabolites, induce DNA fragmentation in Sertoli cells.
Topics: 2-Methoxyestradiol; Animals; Apoptosis; Caspase 3; Cell Line; Cell Survival; Child; DNA Fragmentation; Estradiol; Estrogen Receptor Antagonists; Fulvestrant; Humans; Male; Mice; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Sertoli Cells | 2016 |
Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol.
Topics: 2-Methoxyestradiol; Antineoplastic Agents, Hormonal; Apoptosis; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Fulvestrant; Gene Expression Regulation, Neoplastic; Histones; Humans; Neoplasm Metastasis; Neoplasm Proteins; Osteosarcoma; Phosphorylation; Protein Processing, Post-Translational | 2016 |